Capital International Investors Has $8.48 Million Stake in Agilon Health, Inc. $AGL

Capital International Investors decreased its stake in shares of Agilon Health, Inc. (NYSE:AGL) by 16.8% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 8,232,209 shares of the company’s stock after selling 1,660,533 shares during the period. Capital International Investors owned 1.99% of Agilon Health worth $8,479,000 as of its most recent filing with the SEC.

A number of other institutional investors have also made changes to their positions in AGL. CenterBook Partners LP increased its position in Agilon Health by 492.4% during the third quarter. CenterBook Partners LP now owns 11,428,027 shares of the company’s stock worth $11,771,000 after acquiring an additional 9,499,012 shares during the period. Connor Clark & Lunn Investment Management Ltd. boosted its holdings in Agilon Health by 1,028.9% in the 2nd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 789,703 shares of the company’s stock valued at $1,816,000 after purchasing an additional 719,751 shares during the period. Geode Capital Management LLC grew its position in Agilon Health by 2.6% in the 2nd quarter. Geode Capital Management LLC now owns 7,156,466 shares of the company’s stock worth $16,462,000 after purchasing an additional 178,477 shares during the last quarter. SG Americas Securities LLC grew its position in Agilon Health by 60.1% in the 2nd quarter. SG Americas Securities LLC now owns 230,912 shares of the company’s stock worth $531,000 after purchasing an additional 86,723 shares during the last quarter. Finally, XTX Topco Ltd increased its holdings in shares of Agilon Health by 583.2% during the 2nd quarter. XTX Topco Ltd now owns 400,760 shares of the company’s stock worth $922,000 after purchasing an additional 342,100 shares during the period.

Wall Street Analyst Weigh In

AGL has been the subject of several recent research reports. Royal Bank Of Canada raised Agilon Health from a “hold” rating to a “moderate buy” rating in a report on Wednesday, December 3rd. BTIG Research reissued a “neutral” rating on shares of Agilon Health in a report on Friday, December 12th. Barclays lowered their price objective on Agilon Health from $1.00 to $0.50 and set an “underweight” rating on the stock in a research report on Friday, February 27th. Citigroup cut their target price on Agilon Health from $0.85 to $0.75 and set a “neutral” rating for the company in a research note on Tuesday, March 3rd. Finally, Wells Fargo & Company raised their target price on Agilon Health from $1.00 to $1.50 and gave the stock an “overweight” rating in a research report on Friday, February 27th. Three analysts have rated the stock with a Buy rating, eleven have given a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat, Agilon Health has a consensus rating of “Hold” and a consensus price target of $2.18.

Agilon Health Trading Down 5.2%

AGL stock opened at $0.60 on Friday. The business has a fifty day moving average price of $0.70 and a 200 day moving average price of $0.82. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. Agilon Health, Inc. has a fifty-two week low of $0.34 and a fifty-two week high of $6.08. The stock has a market capitalization of $250.58 million, a price-to-earnings ratio of -0.64 and a beta of 0.11.

Agilon Health (NYSE:AGL) last announced its earnings results on Wednesday, February 25th. The company reported ($0.46) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.19). Agilon Health had a negative return on equity of 120.82% and a negative net margin of 6.60%.The company had revenue of $1.57 billion for the quarter, compared to analyst estimates of $1.46 billion. Analysts expect that Agilon Health, Inc. will post -0.59 EPS for the current fiscal year.

About Agilon Health

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.